Universität Ulm

Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action (2016) Klotz L, Berthele A, Brueck W, Chan A, Flachenecker P, Gold R, Haghikia A, et al. Journal article The analysis of heterotaxy patients reveals new loss-of-function variants of GRK5 (2016) Lessel D, Muhammad T, Tena TC, Moepps B, Burkhalter MD, Hitz MP, Toka O, et al. Journal article Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study (2016) Goebeler ME, Knop S, Viardot A, Kufer P, Topp MS, Einsele H, Noppeney R, et al. Journal article Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses (2016) Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, et al. Journal article Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial (2016) Herrlinger U, Schaefer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, et al. Journal article Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02) (2016) Bauer S, Baier H, Baumgartner C, Bohlmann K, Fauser S, Graf W, Hillenbrand B, et al. Journal article Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016) Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, et al. Journal article DNA methylation in PRDM8 is indicative for dyskeratosis congenita (2016) Weidner CI, Lin Q, Birkhofer C, Gerstenmaier U, Kaifie A, Kirschner M, Bruns H, et al. Journal article High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) (2016) Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, et al. Journal article PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis (2016) Faetkenheuer G, Jessen H, Stoehr A, Jung N, Jessen AB, Kuemmerle T, Berger M, et al. Journal article